Sperzel John J III 4
4 · T2 Biosystems, Inc. · Filed Feb 20, 2024
Insider Transaction Report
Form 4
Sperzel John J III
DirectorSee Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-02-20+160→ 333 total - Exercise/Conversion
Restricted Stock Units
2024-02-20−160→ 160 total→ Common Stock (160 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On February 20, 2022 the reporting person was granted 480 RSU's that vest in three equal annual installments commencing on February 20, 2023